Skip to main content
Equibles
OCUL logo

OCUL · Ocular Therapeutix, Inc · Analyst Estimates

Track OCUL — free

Use OCUL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OCUL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.14 +0.32 (+4.69%) At close · Nov 4 Play latest call Q1 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$1.54B
Shares
219.62M
Volume · Nov 4 3.36M Avg daily vol (3M) 3.04M

Analyst Estimates

Compare analyst forecasts for Ocular Therapeutix, Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-20 14:57 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.54
-1.44
-1.18
5
-1.44
-1.43
-1.43
-1.55
0
0
3
3
Revenue
USD
Publication date not stated
50.80M
52.84M
56.21M
12
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.86
-1.48
-1.09
6
-1.48
-1.45
-1.45
-1.54
1
1
3
3
Revenue
USD
Publication date not stated
57.50M
102.04M
183.00M
12
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.37
-0.35
-0.30
6
-0.35
-0.35
-0.35
-0.39
0
0
4
4
Revenue
USD
Publication date not stated
13.40M
14.30M
16.00M
12
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.43
-0.38
-0.31
6
-0.38
-0.38
-0.38
-0.41
0
0
4
4
Revenue
USD
Publication date not stated
13.20M
14.18M
17.13M
12
 — — — — — — — —
Key facts CIK 1393434 CUSIP 67576A100 13F (30d) 65 filings 65 filers Visit website Investor relations